Benefit Seen in the Use of Intranasal Insulin in Slowing Dementia

By |2019-07-29T16:49:18-07:00July 29th, 2019|Brief Bulletins from the Field, We Know Psychiatry|

Daily intranasal insulin may be effective in slowing progression of mild cognitive impairment (MCI) or Alzheimer's disease (AD), new research suggests. The findings were presented at the Alzheimer's Association International Conference (AAIC) 2019. Investigators found intranasal insulin administered via a novel delivery device slowed the rate of cognitive decline by [...]

Alzheimer’s Therapy Elenbecestat Reduces Brain Amyloid Levels, Trial Shows, but Decline of Clinical Symptoms Still a Question

By |2018-06-08T08:10:58-07:00June 8th, 2018|Brief Bulletins from the Field, Featured, We Know Psychiatry|

Treatment with the investigational compound elenbecestat reduced brain amyloid beta levels and was safe and well-tolerated, according to Phase 2 clinical trial results. The presence of amyloid beta plaques is a major characteristic of the brains of Alzheimer’s disease patients. Amyloid beta is produced through the work of a key enzyme called [...]

Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer’s Disease by Vitamin E and Selenium Trial (PREADViSE)

By |2021-11-11T17:13:46-08:00March 25th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Richard J. Kryscio, Erin L. Abner, Allison Caban-Holt, et al. Key Points Question Can vitamin E or selenium prevent dementia in asymptomatic older men? Findings The Prevention of Alzheimer’s Disease by Vitamin E and Selenium trial initially enrolled 7540 elderly men who were exposed to the supplements for an average [...]

NUTRITIONAL DRINK MAY HELP REDUCE BRAIN SHRINKAGE AND SLOW SYMPTOMS OF ALZHEIMER’S DISEASE, EU STUDY SHOWS

By |2016-03-15T16:20:17-07:00March 15th, 2016|We Know Psychiatry|

In a recent study, researchers looked at the possibility of using nutritional intervention to slow the onset of certain Alzheimer’s symptoms. The study involved a particular nutritional drink called Souvenaid http://www.souvenaid-us.com/, which was given to patients in the pre-dementia (prodromal) stage of Alzheimer’s once a day for a twelve month [...]

Commonly Used P.P.I.s Tied to Brain Disease

By |2016-02-23T20:20:29-08:00February 23rd, 2016|We Know Psychiatry|

Proton Pump Inhibitor's (or P.P.I.s), widely available by prescription or over the counter brands like Prevacid, Nexium, and Prilosec, have been tied to Alzheimer's Disease and other dementias, according to German researchers writing in JAMA Neurology. The researchers looked for five years at 73,679 men and women over 75 who were [...]

Title

Go to Top